Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
MacuCLEAR logo — Pioneering innovative treatments for vascular eye disorders...

MacuCLEAR

Pioneering innovative treatments for vascular eye disorders with promising clinical success.

Founded 2006 Series Unknown Total: $1.00M Biotechnology, Health Care +1

General Information

Company Name MacuCLEAR
Founded Year 2006
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when MacuCLEAR moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MacuCLEAR

MacuCLEAR is a pioneering clinical-stage pharmaceutical company founded in 2006 that specializes in developing innovative treatments for vascular eye disorders. With the slogan "Pioneering innovative treatments for vascular eye disorders with promising clinical success," MacuCLEAR aims to revolutionize the biotechnology, health care, and pharmaceutical industries. The company holds an active IND for MC-1101 and has successfully completed a Phase Ib/POC human clinical trial, showcasing promising progress in its research and development. The last recorded investment for MacuCLEAR was a $1.00M Venture Round investment on 03 January 2012, signifying investor confidence in the company's potential.

Taxonomy: ophthalmology, pharmaceuticals, clinical-stage, vascular eye disorders, innovative treatments, MC-1101, human clinical trial, IND, vascular disorders, clinical trial, drug development, medical research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 03 Jan 2012

MacuCLEAR Alternatives & Competitors

MacuCLEAR vs
Prilenia
Prilenia United States

Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorde...

Series B
57 employees
Biotechnology, Health Care
MacuCLEAR vs
IAMA Therapeutics
IAMA Therapeutics Italy

Our mission is to make a difference in the lives of individuals suffering from neurodevelopmental, c...

Series A
8 employees
Biotechnology, Life Sciences
MacuCLEAR vs
BBB Therapeutics
BBB Therapeutics The Netherlands

Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-brain barr...

Unknown
21 employees
Biopharma, Biotechnology

FAQ About MacuCLEAR

Pioneering innovative treatments for vascular eye disorders with promising clinical success.
MacuCLEAR was founded in 2006.
MacuCLEAR operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
MacuCLEAR has completed 1 funding round, raising a total of $1.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to MacuCLEAR include Prilenia, IAMA Therapeutics, BBB Therapeutics, Imperial Clinical Research Services, X4 Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MacuCLEAR and Prilenia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MacuCLEAR and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy